Document Detail


Population-based case-control teratologic study of topical miconazole.
MedLine Citation:
PMID:  15008899     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Miconazole cream is used in Hungary to treat fungal genital and skin infections in pregnant women, but it causes anxiety for both patients and medical doctors due to the category C classification of the drug regarding teratogenic or fetotoxic risk. The objective of this case-control study was to analyze the teratogenic potential of topical miconazole used during pregnancy in the mothers of babies with congenital abnormalities and in matched control mothers of babies without congenital abnormalities. The population-based data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities between 1980 and 1996 included 22 843 women who had newborns or fetuses with congenital abnormalities, and 38 151 pregnant women who had newborn infants without any defects (controls). In the case group, 24 (0.11%) and in the control group, 46 (0.12%) pregnant women were treated with miconazole (crude odd ratio [OR]: 0.9 with 95% confidence interval [CI]: 0.6-1.6). Different congenital abnormality groups were evaluated in case-control pairs and a higher prevalence of miconazole treatment was not found during the second or third month of pregnancy. Thus, treatment with topical miconazole during pregnancy does not increase the risk of congenital abnormalities.
Authors:
Andrew Endre Czeizel; Zoltán Kazy; Erzsébet Puhó
Related Documents :
10401869 - Risk factor patterns for cryptorchidism and hypospadias.
24445819 - Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting.
15699309 - Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disor...
11320529 - Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled...
9757979 - The safety of omeprazole during pregnancy: a multicenter prospective controlled study.
15255879 - Partner violence during pregnancy and risk of adverse pregnancy outcomes.
25413689 - Successful treatment of severe rhesus d-incompatible pregnancy with repeated double-fil...
17851819 - Maternal anxiety about first trimester nuchal translucency screening and impact of posi...
11914689 - Intrauterine growth restriction.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Congenital anomalies     Volume:  44     ISSN:  0914-3505     ISO Abbreviation:  Congenit Anom (Kyoto)     Publication Date:  2004 Mar 
Date Detail:
Created Date:  2004-03-10     Completed Date:  2004-12-21     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9306292     Medline TA:  Congenit Anom (Kyoto)     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  41-5     Citation Subset:  IM    
Affiliation:
Foundation for the Community Control of Hereditary Diseases, Budapest, Hungary. czeizel@interware.hu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abnormalities, Drug-Induced / physiopathology*
Administration, Topical
Adult
Antifungal Agents / administration & dosage,  adverse effects,  pharmacology*
Case-Control Studies
Female
Humans
Miconazole / administration & dosage,  adverse effects,  pharmacology*
Pregnancy
Chemical
Reg. No./Substance:
0/Antifungal Agents; 22916-47-8/Miconazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  High molecular weight microtubule-associated protein 2 over-expression in neuronal migration disorde...
Next Document:  Abnormal expression of tyrosine hydroxylase not accompanied by phosphorylation at serine 40 in cereb...